Combined PET imaging of the inflammatory tumor microenvironment identifies margins of unique radiotracer uptake.

Zinnhardt B, Pigeon H, Thézé B, Viel T, Wachsmuth L, Fricke IB, Schelhaas S, Honold L, Schwegmann K, Wagner S, Faust A, Faber C, Kuhlmann MT, Hermann S, Schäfers M, Winkeler A, Jacobs AH. (2017)
In: Cancer Research, 77(8)
Art der Publikation: Forschungsartikel (Zeitschrift)

Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid…

Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs A, Brüning R, Heindel W, Ringelstein E, Stummer W, Pluta R, Hesselmann V. (2016)
In: Journal of Neurosurgery, 124(1)
Art der Publikation: Forschungsartikel (Zeitschrift)

The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models.

Heinzmann K, Honess D, Lewis D, Smith D, Cawthorne C, Keen H, Heskamp S, Schelhaas S, Witney T, Soloviev D, Williams K, Jacobs A, Aboagye E, Griffiths J, Brindle K. (2016)
In: EJNMMI Research, 6(1)
Art der Publikation: Forschungsartikel (Zeitschrift)

Gemcitabine mechanism of action confounds early assessment of treatment response by 3′-Deoxy-3′-[18F]fluorothymidine in preclinical models of lung cancer.

Schelhaas S, Held A, Wachsmuth L, Hermann S, Honess D, Heinzmann K, Smith D, Griffiths J, Faber C, Jacobs A. (2016)
In: Cancer Research, 76(24)
Art der Publikation: Forschungsartikel (Zeitschrift)

Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers.

O’Halloran P, Viel T, Murray D, Wachsmuth L, Schwegmann K, Wagner S, Kopka K, Jarzabek M, Dicker P, Hermann S, Faber C, Klasen T, Schäfers M, O’Brien D, Prehn J, Jacobs A, Byrne A. (2016)
In: European Journal of Nuclear Medicine and Molecular Imaging, 43(9)
Art der Publikation: Forschungsartikel (Zeitschrift)

Publikationen

Kontakt

Top-Links

A specific dietary intervention to restore brain structure and function after ischemic stroke. Wiesmann M, Zinnhardt B, Reinhardt D, Eligehausen S, Wachsmuth L, Hermann S, Dederen PJ, Hellwich M, Kuhlmann MT, Broersen LM, Heerschap A, Jacobs AH, Kiliaan AJ. (2017) In: Theranostics, 7(2) Art der Publikation: Forschungsartikel (Zeitschrift)
Combined PET imaging of the inflammatory tumor microenvironment identifies margins of unique radiotracer uptake. Zinnhardt B, Pigeon H, Thézé B, Viel T, Wachsmuth L, Fricke IB, Schelhaas S, Honold L, Schwegmann K, Wagner S, Faust A, Faber C, Kuhlmann MT, Hermann S, Schäfers M, Winkeler A, Jacobs AH. (2017) In: Cancer Research, 77(8) Art der Publikation: Forschungsartikel (Zeitschrift)
In vivo bioluminescence imaging of neurogenesis - the role of the blood brain barrier in an experimental model of Parkinson's disease. Fricke IB, Schelhaas S, Zinnhardt B, Viel T, Hermann S, Couillard-Després S, Jacobs AH. (2017) In: Eur J Neurosci., ejn.13540 Art der Publikation: Forschungsartikel (Zeitschrift)
Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid… Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs A, Brüning R, Heindel W, Ringelstein E, Stummer W, Pluta R, Hesselmann V. (2016) In: Journal of Neurosurgery, 124(1) Art der Publikation: Forschungsartikel (Zeitschrift)
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Jacobs AH, Wiek C, Roellecke K, Hanenberg H, Hartmann W, Wiendl H, Pankratz S, Meltzer J, Farwick N, Greune L, Fluegge M, Rossig C. (2016) In: OncoImmunology, 6(1) Art der Publikation: Forschungsartikel (Zeitschrift)
The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models. Heinzmann K, Honess D, Lewis D, Smith D, Cawthorne C, Keen H, Heskamp S, Schelhaas S, Witney T, Soloviev D, Williams K, Jacobs A, Aboagye E, Griffiths J, Brindle K. (2016) In: EJNMMI Research, 6(1) Art der Publikation: Forschungsartikel (Zeitschrift)
Preclinical evidence that 3′-deoxy-3′-[18F]fluorothymidine PET can visualize recovery of hematopoiesis after gemcitabine chemotherapy. Schelhaas S, Held A, Bäumer N, Viel T, Hermann S, Müller-Tidow C, Jacobs A. (2016) In: Cancer Research, 76(24) Art der Publikation: Forschungsartikel (Zeitschrift)
Gemcitabine mechanism of action confounds early assessment of treatment response by 3′-Deoxy-3′-[18F]fluorothymidine in preclinical models of lung cancer. Schelhaas S, Held A, Wachsmuth L, Hermann S, Honess D, Heinzmann K, Smith D, Griffiths J, Faber C, Jacobs A. (2016) In: Cancer Research, 76(24) Art der Publikation: Forschungsartikel (Zeitschrift)
6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable… Fricke I, Viel T, Worlitzer M, Collmann F, Vrachimis A, Faust A, Wachsmuth L, Faber C, Dollé F, Kuhlmann M, Schäfers K, Hermann S, Schwamborn J, Jacobs A. (2016) In: European Journal of Neuroscience, 43(10) Art der Publikation: Forschungsartikel (Zeitschrift)
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers. O’Halloran P, Viel T, Murray D, Wachsmuth L, Schwegmann K, Wagner S, Kopka K, Jarzabek M, Dicker P, Hermann S, Faber C, Klasen T, Schäfers M, O’Brien D, Prehn J, Jacobs A, Byrne A. (2016) In: European Journal of Nuclear Medicine and Molecular Imaging, 43(9) Art der Publikation: Forschungsartikel (Zeitschrift)